Resorbable pouches for implantable medical devices

• US 9,023,114 B2
• Filed: 11/06/2007
• Issued: 05/05/2015
• Est. Priority Date: 11/06/2006
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: TYRX, INC. (Medtronic Plc)
• Inventors: Buevich, Fatima, Do, Frank, McJames, William, Edelman, William, Moses, Arikha, Diamond, Mason
• Primary Examiner(s): Berdichevsky, Aarti B
• Assistant Examiner(s): OSINSKI, BRADLEY JAMES
• Application Number:
  US11/936,051
• Publication Number:
  US 20080128315A1
• Time in Patent Office: 2,737 Days
• Field of Search: 604/19, 424/424, 424/426, 606/151, 606/154, 623/11.11, 623/23.75, 427/2.31, 206363-368, 206/572, 607/126
• US Class Current: 623/23.75
• CPC Class Codes: A61B 2017/00004 (bio)absorbable, (bio)resorbable, resorptive for implantable prostheses A61F2210/0004
• CPC Class Codes: A61B 2017/00889 antimicrobial, disinfectant
• CPC Class Codes: A61B 2017/00893 pharmaceutically effective
• CPC Class Codes: A61B 2050/314 Flexible bags or pouches
• CPC Class Codes: A61B 2090/0815 Implantable devices for insertion in between organs or other soft tissues
• CPC Class Codes: A61B 50/30 Containers specially adapted for packaging, protecting, dispensing, collecting or disposing of surgical or diagnostic appliances or instruments for wound clamps A61B17/10; for ligaturing clips A61B17/122; packages or dispensers for surgical gloves or finger-stalls A61B42/40
• CPC Class Codes: A61K 31/195 having an amino group
• CPC Class Codes: A61K 31/445 Non condensed piperidines, e.g. piperocaine
• CPC Class Codes: A61K 31/496 Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
• CPC Class Codes: A61L 2300/00 Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
• CPC Class Codes: A61L 2300/45 Mixtures of two or more drugs, e.g. synergistic mixtures
• CPC Class Codes: A61L 2400/18 Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
• CPC Class Codes: A61L 31/04 Macromolecular materials
• CPC Class Codes: A61L 31/148 Materials at least partially resorbable by the body
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence
• CPC Class Codes: A61N 1/375 Constructional arrangements, e.g. casings
• CPC Class Codes: A61N 1/37512 Pacemakers
• CPC Class Codes: A61P 23/00 Anaesthetics
• CPC Class Codes: A61P 31/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

Biodegradable and resorbable polymer pouches are described for use with cardiac rhythm mamagent devices (CRMs) and other implantable medical devices (IMDs), i.e., a pouch, covering, or other receptacle capable of encasing, surrounding and/or holding the CRM or other IMD for the purpose of securing it in position, inhibiting or reducing bacterial growth, providing pain relief and/or inhibiting scarring or fibrosis on or around the CRM or other IMD. Optionally, the biodegradable and resorbable pouches of the invention include one or more drugs in the polymer matrix to provide prophylactic effects and alleviate side effects or complications associated with the surgery or implantation of the CRM or other IMD.

Claims

1. A resorbable pouch comprising

(a) a biodegradable and resorbable polymer formed to at least partially enclose or encase a cardiac rhythm management device, wherein said pouch is configured to permit ingrowth of tissue into said pouch to resist post implantation migration of said cardiac rhythm management device;

and

(b) one or more drugs, said pouch having a porosity sufficient to electrically ground the device to tissue surrounding said resorbable pouch, wherein said pouch removably encloses or encases said cardiac rhythm management device, and wherein said one or more drugs is selected from the group consisting of an antimicrobial agents, anesthetics, anti-inflammatory agents, and leukotriene inhibitors;

wherein the resorbable pouch is a thermoformed clamshell type pouch having a first half and a second half connected by a hinge.

2. The resorbable pouch of claim 1, wherein said drug is bupivacaine HCl.

3. The resorbable pouch of claim 1, wherein said drug is an antimicrobial agent.

4. The resorbable pouch of claim 3, comprising two antimicrobial agents, said agents being rifampin and a tetracycline derivative.

5. The resorbable pouch of claim 4, wherein said tetracycline derivative is minocycline HCl.

6. The pouch of claim 3, wherein said antimicrobial agent is selected from the group consisting of rifampin, minocycline, silver/chlorhexideine, vancomycin, a cephalosporin, gentamycin, triclosan and combination thereof.

7. The pouch of claim 1, wherein said one or more biodegradable polymers are selected from the group consisting of a polylactic acid, polyglycolic acid, poly(L-lactide), poly(D,L-lactide), polyglycolic acid, poly(L-lactide-co-D,L-lactide), poly (L-lactide-co-glycolide), poly(D,L-lactide-co-glycolide), poly (glycolide-co-trimethlylene carbonate) poly(D,L-lactide-co-caprolactone), poly(glycolide-co-caprolactone), polyethylene oxide, polyoxaester, polydioxanone, polypropylene fumarate, poly (ethyl glutamate-co-glutamic acid), poly (tert-butyloxy-carbonylmethyl glutamate), polycaprolactone, polycaprolactone co-butylacrylate, polyhydroxybutyrate, poly (phosphazene), poly (phosphate ester), poly (amino acid), polydepsipeptide, maleic anhydride copolymer, polyiminocarbonates, poly[(97.5%) dimethyl-trimethylene carbonate)-co-(2.5% trimethylene carbonate)], poly(orthoesters), tyrosine-derived polyarylate, tyrosine-derived polycarbonate, tyrosine-derived polyiminocarbonate, tyrosine-derived polyphosphonate, polyalkylene hydroxypropylmethylcellulose, polysaccharide, copolymers, terpolymers and blends of any thereof.

8. The pouch of claim 7, wherein at least one of said biodegradable polymers comprise one or more tyrosine-derived diphenol monomer units.

9. The pouch of claim 1, wherein said pouch covers no more than 50% of said device.

10. The resorbable pouch of claim 1, wherein said pouch comprises pores, voids, or holes having a size of about 0.12 inches.

11. The resorbable pouch of claim 1, further comprising said cardiac rhythm management device, wherein at least a portion of an outer surface of said cardiac rhythm management device is spaced apart from an inner surface of said pouch.

12. The resorbable pouch of claim 1, wherein said cardiac rhythm management device is removable from said pouch prior to implantation of said pouch.

13. The resorbable pouch of claim 12, wherein said cardiac rhythm management device is fixed relative to said pouch following implantation of said pouch.

14. The resorbable pouch of claim 1, wherein said cardiac rhythm management device is movable within said pouch prior to implantation of said pouch.

15. The resorbable pouch of claim 1, wherein said cardiac rhythm management device is fixed relative to said pouch following implantation of said pouch.

16. The resorbable pouch of claim 1, wherein said pouch comprises at least one surface comprising a plurality of voids, said voids being uniformly distributed along said at least one surface.

17. The resorbable pouch of claim 1, wherein said pouch comprises at least one surface comprising a plurality of voids, said voids being evenly spaced apart from one another.

18. The resorbable pouch of claim 1, wherein said pouch comprises at least one surface comprising a plurality of voids, said voids each having a like configuration.

19. The resorbable pouch of claim 1, further comprising said cardiac rhythm management device, wherein said cardiac rhythm management device comprises at least one lead that extends through an opening in said pouch.

20. The resorbable pouch of claim 1, wherein said biodegradable and resorbable polymer has a molecular weight between about 10,000 and about 200,000 Daltons.

21. The resorbable pouch of claim 1, wherein said biodegradable and resorbable polymer comprises between 2% and 50% of said one or more drugs at room temperature.

22. The resorbable pouch of claim 1, wherein said biodegradable and resorbable polymer is configured to release said one or more drugs for at least 2 to 3 days.

23. The resorbable pouch of claim 1, wherein said biodegradable and resorbable polymer comprises a plurality of layers.

24. The resorbable pouch of claim 23, wherein each of said layers comprises a different polymer.

25. The resorbable pouch of claim 23, wherein each of said layers comprises a first polymer.

26. The resorbable pouch of claim 23, wherein each of said layers comprises a different drug.

27. The resorbable pouch of claim 23, wherein each of said layers comprises first drug.

28. The resorbable pouch of claim 1, wherein said pouch has a thickness between about 2 and about 400 microns.

29. The resorbable pouch of claim 1, further comprising said cardiac rhythm management device, wherein said cardiac rhythm management device comprises leads and said thermoformed clamshell type pouch comprises a space to said leads pass through.

30. A resorbable pouch comprising a biodegradable and resorbable polymer formed to at least partially enclose or encase an implantable medical device, wherein said device is a pacemaker, a defibrillator, a pulse generator, an implantable access system, a drug pump or a neurostimulator, wherein said pouch is configured to permit ingrowth of tissue into said pouch to resist post implantation migration of said device, and wherein said pouch has a porosity sufficient to electrically ground the device to tissue surrounding the resorbable pouch, wherein said pouch removably encloses or encases said implantable medical device and the resorbable pouch is a thermoformed clamshell type pouch having a first half and a second half connected by a hinge.

31. The resorbable pouch of claim 30, wherein said porosity contributes to a percentage of the medical device covered by said pouch.

32. The resorbable pouch of claim 30, wherein said pouch comprises a film having 50% pores, voids, or holes.

33. The resorbable pouch of claim 30, wherein said pouch is woven or knit from resorbable fibers, or made from electrospun resorbable fibers.

34. A resorbable pouch comprising

(a) a cardiac rhythm management device;

(b) a biodegradable and resorbable polymer formed to at least partially enclose or encase the cardiac rhythm management device, wherein said pouch secures said cardiac rhythm management device into position after implantation; and

(c) one or more drugs, said pouch having a porosity sufficient to electrically ground the device to tissue surrounding said resorbable pouch, wherein said pouch removably encloses or encases said cardiac rhythm management device, and wherein said one or more drugs is selected from the group consisting of an antimicrobial agents, anesthetics, anti-inflammatory agents, and leukotriene inhibitors,

wherein said cardiac rhythm management device is removable from said pouch prior to implantation of said pouch and said cardiac rhythm management device is fixed relative to said pouch following implantation of said pouch and wherein the resorbable pouch is a thermoformed clamshell type pouch having a first half and a second half connected by a hinge.

35. The resorbable pouch of claim 34, wherein pouch is configured to permit ingrowth of tissue into said pouch to resist post implantation migration of said cardiac rhythm management device.